Instalab
logoInstalab

Isovalerate

Stool Test
Get an early read on how your gut bacteria are handling protein, a window standard digestive labs do not offer.
4.9 (3,578 reviews)
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Collect your sample
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Isovalerate test?

This test is most useful if any of these apply to you.

Working on Your Gut Health
If you are deliberately changing your diet, microbiome, or fiber intake, this gives you a direct readout of how your bacteria are responding.
Eating High-Protein, Low-Fiber
If you eat heavy on protein and light on plants, this shows whether undigested protein is reaching your colon and feeding the wrong fermentation.
Managing Metabolic or Liver Issues
Branched short-chain fatty acids are emerging signals in metabolic and liver disease, offering an exploratory window beyond standard labs.
Healthy but Tracking Aging
These markers rise with age, so a baseline now gives you a personal reference point to compare against in the years ahead.

About Isovalerate

Most of what happens in your colon is invisible from a routine stool test. Bacteria there are constantly fermenting whatever reaches them, and the by-products they leave behind tell you which type of fermentation is dominating. Isovalerate is one of those by-products, and it is specifically a fingerprint of bacteria breaking down protein rather than fiber.

Knowing your level is useful because protein fermentation is generally considered the less desirable mode of bacterial activity. A consistently high reading can suggest your gut microbes are leaning toward putrefactive metabolism, often because fiber is in short supply or protein is reaching the colon undigested. This number is one of the few ways to see that pattern directly.

What Isovalerate Actually Measures

Isovalerate (also called isovaleric acid) is one of three branched short-chain fatty acids, or BCFAs, that gut bacteria produce when they ferment branched-chain amino acids like leucine. The other two BCFAs commonly measured alongside it are isobutyrate and 2-methylbutyrate. Together, these are sometimes called putrefactive SCFAs, a term that distinguishes them from the saccharolytic SCFAs (acetate, butyrate, and propionate) that bacteria make when they ferment fiber.

When your fiber intake is high and protein digestion in the small intestine is efficient, most colonic fermentation is saccharolytic and your fecal BCFAs stay relatively low. When fiber is low or undigested protein reaches the colon, bacteria pivot to amino-acid fermentation, and isovalerate rises. The number on your report is therefore less about a single disease and more about which fermentation pathway your microbiome is favoring.

Aging and Diet Patterns

In a study of 232 adults across the lifespan, fecal branched short-chain fatty acids rose with age but were not associated with body mass index. The same study found a negative correlation between fecal BCFA levels and dietary insoluble fiber intake, meaning people eating more insoluble fiber tended to have lower fecal BCFAs. This is consistent with the basic biology: more fiber means more saccharolytic fermentation and proportionally less protein-driven fermentation.

What this means for you: a higher-than-expected isovalerate is often a prompt to look at your fiber intake before assuming anything is wrong with your gut bacteria themselves.

Gut and Metabolic Health Signals

Direct outcome data linking stool isovalerate to hard endpoints like heart attack, cancer, or death does not yet exist. The signals that do exist come from observational comparisons of fecal SCFA profiles between people with and without specific conditions.

In a study of 109 people, those with essential tremor had lower fecal short-chain fatty acid levels than controls, and the changes tracked with clinical severity and gut microbiota differences. In a study of 77 older adults, the fecal microbiome and metabolome differed between heart failure patients with and without sarcopenia (age-related muscle loss), pointing to gut bacterial output as a possible factor in muscle wasting. These are exploratory associations rather than proof that isovalerate causes any of these conditions.

Evidence from blood-based measurements (a different specimen from this stool test) adds another layer. In a study of 259 people with type 2 diabetes, lower circulating isobutyrate and methylbutyrate were associated with more severe non-alcoholic fatty liver disease. Whether stool isovalerate follows the same pattern has not been directly tested, so this finding should be read as suggestive of a broader role for branched short-chain fatty acids in metabolic health, not as direct evidence about your stool number.

Reference Ranges

There are no standardized clinical cutpoints for stool isovalerate. The number you receive is best read as orientation, not a verdict. Different labs use different methods (commonly gas chromatography or mass spectrometry) and report results in different units, most often micrograms per gram of stool. Compare your results within the same lab over time for the most meaningful trend, and avoid treating any single threshold as a hard target.

What clinicians and researchers usually look at instead is the ratio of putrefactive to saccharolytic SCFAs and the trend in your own readings. A rising isovalerate alongside falling butyrate, for example, is more informative than either number alone.

When Results Can Be Misleading

  • Recent diet changes: a high-protein, low-fiber day or two before collection can shift fermentation patterns and push isovalerate up. The number reflects what you have been eating recently, not just your long-term gut state.
  • Sample handling: branched short-chain fatty acids are volatile, and delays in shipping or improper storage can lower the measured level. Follow your lab's collection and shipping instructions exactly.
  • Antibiotics: a recent course can dramatically alter your microbial community and the SCFAs they produce. A reading taken within weeks of antibiotics may not represent your usual state.
  • Bowel transit: very fast or very slow transit changes how long bacteria have to ferment substrates and can shift the proportions of different SCFAs.

Tracking Your Trend

Stool isovalerate has high day-to-day variability because it depends on what you ate, how your bacteria responded, and how long the contents took to reach your colon. A single reading is a snapshot, not a verdict. The most useful thing you can do is establish a baseline, make targeted dietary changes, and retest under similar conditions a few months later.

A reasonable approach: get a baseline test, retest at 3 to 6 months if you are deliberately changing your fiber or protein intake, and at least annually thereafter. Pay attention to the direction of change, not the absolute number. Because this is a research-stage marker without consensus thresholds, your own trend lines are the most reliable signal you have.

What to Do With an Abnormal Result

An isolated high or low isovalerate is rarely actionable on its own. The number gains meaning when you read it alongside the rest of your stool fermentation profile and any digestive symptoms you have.

If your isovalerate is elevated, the most informative next step is to look at the full SCFA panel: are isobutyrate and 2-methylbutyrate also high (suggesting a broad shift toward protein fermentation), and is butyrate suppressed (suggesting fiber-fermenting bacteria are underrepresented)? Markers of pancreatic enzyme output (such as pancreatic elastase 1) and overall microbial diversity can help clarify whether undigested protein or low fiber substrate is the bigger driver. If you have ongoing digestive symptoms, weight changes, or a known inflammatory bowel condition, a gastroenterologist or a clinician comfortable with functional stool testing is the right next call.

What Moves This Biomarker

Evidence-backed interventions that affect your Isovalerate level

Decrease
Eat more insoluble fiber
Higher dietary insoluble fiber intake is associated with lower fecal branched short-chain fatty acids, including isovalerate. In a study of 232 adults across the lifespan, insoluble fiber intake showed a negative correlation with fecal BCFA levels, consistent with the idea that more fiber pushes gut bacteria toward fiber fermentation and away from protein fermentation.
DietModerate Evidence
Up & Down
Eat arabinoxylan and resistant starch
A randomized crossover trial in 19 adults with metabolic syndrome found that diets enriched with arabinoxylan and resistant starch shifted gut microbial composition and the fecal short-chain fatty acid profile, generally favoring saccharolytic over putrefactive fermentation. The net effect on isovalerate specifically depends on the balance of substrate types in the diet.
DietModerate Evidence
Increase
Aging
Fecal branched short-chain fatty acids, including isovalerate, rise with age. In a study of 232 adults, fecal BCFAs were positively related to aging but not to body mass index. This is a passive trend rather than an intervention, but it explains why age-matched comparisons matter when interpreting your number.
LifestyleModerate Evidence
Decrease
Eat sustainably produced sourdough bread daily
In a study of 40 adults, daily sourdough bread intake was associated with shifts in colonic microbial metabolism toward more saccharolytic SCFA synthesis and free amino acid availability. This pattern tends to lower the relative contribution of putrefactive fermentation, which produces isovalerate.
DietModest Evidence

Frequently Asked Questions

References

6 studies
  1. Ríos-covian D, González S, Nogacka a, Arboleya S, Salazar N, Gueimonde M, De Los Reyes-gavilán CGFrontiers in Microbiology2020
  2. Hald S, Schioldan AG, Moore M, Dige a, Lærke H, Agnholt J, Bach Knudsen KB, Hermansen K, Marco M, Gregersen S, Dahlerup JPLoS ONE2016
  3. Da Ros a, Polo a, Rizzello C, Acín-albiac M, Montemurro M, Di Cagno R, Gobbetti MMicrobiology Spectrum2021
  4. Peng J, Gong H, Lyu X, Liu Y, Li S, Tan S, Dong L, Zhang XFrontiers in Cellular and Infection Microbiology2023